Skip to content

Assessment of a Skin Barrier

User Assessment of a One-Piece Skin Barrier

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02042677
Enrollment
18
Registered
2014-01-23
Start date
2014-01-31
Completion date
2014-09-30
Last updated
2015-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ileostomy

Keywords

ileostomy, 1-piece, assessment, Nova, NovaLife, Dansac

Brief summary

This evaluation is being conducted to determine user perception of a new flat one-piece skin barrier compared to their normal barrier.

Detailed description

Design: This is a multi-site, unblinded, historically controlled assessment of a one-piece flat skin barrier. Study barriers are CE-marked. Approximately 30 subjects are enrolled in the UK.

Interventions

None listed

Sponsors

St George's Healthcare NHS Trust
CollaboratorOTHER
London North West Healthcare NHS Trust
CollaboratorOTHER
Hollister Incorporated
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. is at least 18 years of age. 2. has an ileostomy. 3. is at least six weeks postoperative. 4. lives and cares for their stoma independently in the community. 5. currently uses a Dansac Nova or NovaLife 1-piece flat skin barrier. 6. currently uses a drainable pouch. 7. is able to wear a 1-piece flat cut-to-fit 10-55 mm. 8. Has a peristomal skin irritation score of 2 or less. 9. is willing to follow the protocol as demonstrated by signing the informed consent and who in the opinion of the investigator is qualified to participate.

Exclusion criteria

1. has a fistula on or near the stoma. 2. has been involved in a study involving stoma care with in the last 30 days. 3. is pregnant or lactating, as determined by interview only. 4. is undergoing chemotherapy, radiation or steroid therapy. 5. has an existing medical condition that would compromise their participation in the study.

Design outcomes

Primary

MeasureTime frameDescription
barrier adhesion10 daysQuestionnaire will be provided to subject to assess barrier adhesion.
barrier tack10 daysQuestionnaire will be provided to subject to assess barrier tack.
comfort10 daysQuestionnaire will be provided to subject to assess comfort.
leakage10 daysQuestionnaire will be provided to subject to assess leakage.
ease of barrier removal10 daysQuestionnaire will be provided to subject to assess ease of barrier removal.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026